ID
43784
Description
This study evaluates the effectiveness and safety of MFNS in improving the Treatment of Chronic Sinusitis. ODM derived from:"Randomized Double-blind Clinical Trial on the Efficacy and Safety of 200 mcg BID Mometasone Furoate Nasal Spray (MFNS) or Placebo in the Treatment of Chronic Sinusitis". Leader of the clinical trial: Prof. Dr. med. Karl Hörmann Direktor der Hals-Nasen-Ohren-Klinik / Clinic Director Ear, Nose and Throat Clinic Medical Faculty Mannheim Heidelberg University at the University Medical Centre Mannheim Theodor-Kutzer-Ufer 1-3 68167 Mannheim
Keywords
Versions (2)
- 3/8/16 3/8/16 -
- 9/20/21 9/20/21 -
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Study schedule - Clinical Trial on the Efficacy and Safety BID Mometasone Furoate Nasal Spray (MFNS) in the Treatment of Chronic Sinusitis
Study schedule
- StudyEvent: ODM
Description
Concomitant medication
Description
Admissable Concomitant medication
Data type
integer
Alias
- UMLS CUI [1]
- C2347852
Description
The following drugs may not be used prior to initial examination, and may also not be used during the trial.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0683610
- UMLS CUI [1,2]
- C0013227
Similar models
Study schedule
- StudyEvent: ODM
C0278350 (UMLS CUI-2)
C0489531 (UMLS CUI-3)
C0014245 (UMLS CUI-2)
C0031809 (UMLS CUI-2)
C0037199 (UMLS CUI-2)
C1145675 (UMLS CUI-2)
C0013227 (UMLS CUI [1,2])
C0019590 (UMLS CUI-2)
C0019590 (UMLS CUI-2)
C0019590 (UMLS CUI-2)
C0595724 (UMLS CUI-3)
C0081408 (UMLS CUI-5)